J

Janssen Pharmaceutica (Public limited company)

GMED HEALTHCARE, Janssen EDC, JANSSEN Pharmaceutica NV, Janssen Research & Development, Johnson & Johnson, J&J, Johnson & Johnson Innovative Medicine, J&J Innovative Medicine
BE 0403.834.160 Active ●Turnhoutseweg 30, 2340 Beerse

Janssen Pharmaceutica is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0403.834.160. It was founded on 23-10-1934. Its registered office is in Beerse. Its main activity is: Manufacture of basic pharmaceutical products and pharmaceutical preparations. Its annual accounts for 2025 report equity of € 11 677 693 137 and a profit of € 1 462 262 938. These accounts report 5324.5 full-time equivalents. Addrly gives it a financial health grade of A, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.

Information last updated on 07-10-2026.

Company information

Status
Active
Enterprise number
BE 0403.834.160
VAT registered
Yes
Founded
23-10-1934
Latest accounts
2025
Employees
5324.5 FTE
Region
Flanders
Establishments
12
Filing record
On time 4 of 4 years
Peppol e-invoicing
Registered
Registered office
Turnhoutseweg 30, 2340 Beerse
Main activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
NACE activities
21201 Fabrication de médicaments
63100 Infrastructure informatique, traitement de données, hébergement et activités connexes
71209 Autres activités de contrôle et analyses techniques

Key figures of Janssen Pharmaceutica

202520242023
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ 1 462 262 938-44 %€ 2 633 412 401+9 %€ 2 416 065 934
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ 11 677 693 137+12 %€ 10 464 318 045+6 %€ 9 830 842 656
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 21 578 214 816+3 %€ 20 944 078 135+7 %€ 19 615 807 471
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
---
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
5324.5+2 %5209.9+1 %5159.2

Financial estimate

Financial health grade A, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
25 mandates on record in the annual accounts. 5 of them started since 2024.
Create a free account

Similar companies

Other companies in the same activity nearby.

CompanyTown
PFIZER MANUFACTURING BELGIUM 2870 Puurs-Sint-Amands
Organon Heist 2220 Heist-op-den-Berg
Kaneka Belgium 2260 Westerlo
DE CEUSTER MESTSTOFFEN 2280 Grobbendonk
CAPSUGEL BELGIUM 2880 Bornem
MEDICA 2550 Kontich
Novartis Manufacturing 2870 Puurs-Sint-Amands
LABORATORIA QUALIPHAR 2880 Bornem
Looking for more information about Janssen Pharmaceutica?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is Janssen Pharmaceutica still active? Yes. The Crossroads Bank for Enterprises lists Janssen Pharmaceutica as active.

What is the VAT number of Janssen Pharmaceutica? The VAT number of Janssen Pharmaceutica is BE 0403.834.160.

When was Janssen Pharmaceutica founded? Janssen Pharmaceutica was founded on 23-10-1934.

What is the address of Janssen Pharmaceutica? The current registered office of Janssen Pharmaceutica is Turnhoutseweg 30, 2340 Beerse.

When did Janssen Pharmaceutica last file annual accounts? The latest annual accounts of Janssen Pharmaceutica were filed on 23-06-2026.

Does Janssen Pharmaceutica file its annual accounts on time? Yes. Janssen Pharmaceutica filed its annual accounts within the legal deadline for each of its last 4 financial years.

How many employees does Janssen Pharmaceutica have? Janssen Pharmaceutica employs 5324.5 full-time equivalents according to its most recent annual accounts.

Is Janssen Pharmaceutica financially healthy? Addrly gives Janssen Pharmaceutica a financial health grade of A, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is Janssen Pharmaceutica profitable? The annual accounts of Janssen Pharmaceutica for 2025 show a profit of € 1 462 262 938.

What is the equity of Janssen Pharmaceutica? The equity of Janssen Pharmaceutica was € 11 677 693 137 at the close of the 2025 financial year.

Who are the directors of Janssen Pharmaceutica? The annual accounts of Janssen Pharmaceutica record 25 mandates. The names, roles and dates are visible with a free account.

Can Janssen Pharmaceutica receive Peppol e-invoices? Yes. Janssen Pharmaceutica is registered on the Peppol network and can receive structured electronic invoices.

What does Janssen Pharmaceutica do? The main activity of Janssen Pharmaceutica is: Manufacture of basic pharmaceutical products and pharmaceutical preparations.

Sources

How Addrly builds and refreshes this data